Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
about
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulationGuidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsSilver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patientsProbiotics for preventing ventilator-associated pneumoniaProbiotics for preventing ventilator-associated pneumoniaSilver coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patientsShort-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsShort course versus prolonged course antibiotic therapy for hospital-acquired pneumonia in critically ill adultsCosts and risk factors for ventilator-associated pneumonia in a Turkish university hospital's intensive care unit: a case-control studyVentilator-associated pneumonia in the ICUMicrobial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance PatternsLung ultrasound: a promising tool to monitor ventilator-associated pneumonia in critically ill patientsSystematic review of the association between respiratory diseases and oral healthVentilator associated pneumonia and transfusion, is there really an association? (the NAVTRA study).Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort studyTowards computerizing intensive care sedation guidelines: design of a rule-based architecture for automated execution of clinical guidelines."The National Surgery Quality Improvement Project" (NSQIP): a new tool to increase patient safety and cost efficiency in a surgical intensive care unit.Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study.Impact of four sequential measures on the prevention of ventilator-associated pneumonia in cardiac surgery patients.Do heart and respiratory rate variability improve prediction of extubation outcomes in critically ill patients?Prevention of ventilator-associated pneumonia, mortality and all intensive care unit acquired infections by topically applied antimicrobial or antiseptic agents: a meta-analysis of randomized controlled trials in intensive care units.Probiotics for disease prevention: a focus on ventilator-associated pneumonia.Long-term medical utilization following ventilator-associated pneumonia in acute stroke and traumatic brain injury patients: a case-control study.Pathogens in the lower respiratory tract of intensive care unit patients: impact of duration of hospital care and mechanical ventilation.Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trialEmerging and resistant infectionsImpact of ventilator-associated pneumonia on resource utilization and patient outcome.A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting.Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort studyA national survey of the diagnosis and management of suspected ventilator-associated pneumonia.Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia.How to approach and treat VAP in ICU patients.Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".Atherosclerotic heart disease: prevalence and risk factors in hospitalized men with haemophilia AEpidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals.Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.The tracheal tube: gateway to ventilator-associated pneumonia.Infection control in the intensive care unit.
P2860
Q21254582-773BD656-5CEC-472D-BEE8-6312EDCF61D6Q22241905-051F27AE-CBF5-426E-A162-F9A33518F816Q24187768-442B914C-D5FA-44AF-BC01-F8196489E32AQ24187916-03A1E703-4941-49E1-98F3-233EB5C1293DQ24193079-AB3CBF98-C2B5-460A-8F78-ED4D7D3A1A87Q24235329-A96BE9AA-C73C-42F5-B313-8910C3302C8AQ24235792-B665504A-146D-473D-B052-BE2BA3F95606Q24236108-52DFD373-BA48-48B8-8999-C06184EB1790Q24242739-84B693DC-E201-47C6-AA11-3EA39D152B82Q24803442-91C2CBB0-F5A5-4D89-B043-EC749F4B4FB5Q26862843-6D4264D5-5B8C-4B0A-8A46-0C8FCBAC8D4BQ28069467-1A2BBCB5-04D3-41C2-AB76-AA169B2EC8D9Q28074609-89B1FF69-8396-4361-8905-FD8E8EA3E1FFQ28261106-397E6AF3-AFBA-4844-B655-84ABBFD5D6D3Q30820415-5C026C3F-4F74-4737-9958-452F0607F3EFQ33360986-603C6E61-17DB-43E0-8E2D-21C5F5D61222Q33524898-5B0FE269-2DAF-4617-824A-D1DED09314ADQ33584420-32517CD5-9006-46BB-A41F-3815B57CA693Q33750544-766E2899-B4D5-4639-BB1B-4F22E63050BEQ33752655-4ACC9A49-A81C-48DE-9B63-D75D08433BF5Q33754718-1A9A59AA-D383-4063-BB35-2FD4C96C1DA5Q33942413-9F42FE83-2C4F-4830-83F6-208E8C7AF7EBQ34033644-D7C0FD78-F04B-42EC-9E85-E54E864295DCQ34062836-3958C689-ABA9-4BEA-9FB8-1B5DEB304619Q34156144-627E7EB4-EB52-4E01-BCC7-45B91531C43CQ34268939-99AA76A6-32BF-472C-8CD6-EA3A3EB82144Q34357419-68AA44C7-D69F-4846-9768-048D2F88AC2DQ34382301-682F21FC-1C5C-4539-92DE-725DE4C14226Q34423725-8A7FA279-7D49-4AEE-83CF-AA8B993083EBQ34626378-2CDC0BCE-BBAA-4AF9-9B4E-97197C779A50Q34627696-81511721-A96E-4E2E-8E3B-F1A7D7FD55EFQ34767855-EF87AD7C-4C3E-46B7-8C52-B05661B46ED7Q34999661-79805BB8-9031-4557-8C4C-56F9D0FE4A3CQ35004845-496020D0-3B2B-47F6-8427-C71637BC4617Q35099758-D5A8FAF6-9342-4511-9EFC-23BF77D758D6Q35100303-D03807A3-CF83-42BA-B176-820988C548C0Q35534273-2156A064-562F-479D-8EE3-B28E8121E2E6Q35669486-182F7173-8D46-483A-8DB5-8DE938D7828AQ35908029-8D918768-2C7E-423F-88B2-4687445BFB3BQ35917560-DF3F9631-58F0-4D44-A5F0-47D487DFEE28
P2860
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
description
im Dezember 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2002
@uk
name
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@en
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@nl
type
label
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@en
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@nl
prefLabel
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@en
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
@nl
P2093
P921
P356
P1433
P1476
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database
@en
P2093
Daniel A Ollendorf
Gerry Oster
Lisa Bellm
Marin H Kollef
Montserrat Vera-Llonch
Rebecca Redman
VAP Outcomes Scientific Advisory Group
P304
P356
10.1378/CHEST.122.6.2115
P407
P50
P577
2002-12-01T00:00:00Z